EP1237901A4 - 28 proteines secretees humaines - Google Patents

28 proteines secretees humaines

Info

Publication number
EP1237901A4
EP1237901A4 EP00976756A EP00976756A EP1237901A4 EP 1237901 A4 EP1237901 A4 EP 1237901A4 EP 00976756 A EP00976756 A EP 00976756A EP 00976756 A EP00976756 A EP 00976756A EP 1237901 A4 EP1237901 A4 EP 1237901A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00976756A
Other languages
German (de)
English (en)
Other versions
EP1237901A1 (fr
Inventor
Steven M Ruben
George A Komatsoulis
Paul A Moore
Charles E Birse
Jian Ni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1237901A1 publication Critical patent/EP1237901A1/fr
Publication of EP1237901A4 publication Critical patent/EP1237901A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP00976756A 1999-11-05 2000-11-01 28 proteines secretees humaines Withdrawn EP1237901A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16358199P 1999-11-05 1999-11-05
US163581P 1999-11-05
US21513300P 2000-06-30 2000-06-30
US215133P 2000-06-30
PCT/US2000/030045 WO2001034626A1 (fr) 1999-11-05 2000-11-01 28 proteines secretees humaines

Publications (2)

Publication Number Publication Date
EP1237901A1 EP1237901A1 (fr) 2002-09-11
EP1237901A4 true EP1237901A4 (fr) 2005-01-12

Family

ID=26859771

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00976756A Withdrawn EP1237901A4 (fr) 1999-11-05 2000-11-01 28 proteines secretees humaines

Country Status (5)

Country Link
EP (1) EP1237901A4 (fr)
JP (1) JP2003520030A (fr)
AU (1) AU1449001A (fr)
CA (1) CA2389305A1 (fr)
WO (1) WO2001034626A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2486300A (en) * 1998-12-30 2000-07-31 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
AU2002239229A1 (en) 2000-12-05 2002-06-18 Wisconsin Alumni Research Foundation Receptor for b. anthracis toxin
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
CA2441006A1 (fr) * 2001-03-08 2002-09-19 Hyseq, Inc. Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline
WO2005000099A2 (fr) * 2003-06-09 2005-01-06 Genzyme Corporation Domaines de facteurs sanguins (bfd)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 24 June 1998 (1998-06-24), "om46d10.s1 Soares _NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:1544083 3', mRNA sequence", XP002292357, Database accession no. AA922217 *
DATABASE EMBL 7 June 1997 (1997-06-07), "zx76a07.r1 Soares ovary tumor NbHOT Homo sapiens cDNA clone IMAGE:809652 5' similar to SW:FBLC_MOUSE Q08878 FIBULIN-1, ISOFORM C PRECURSOR ;", XP002292356, Database accession no. AA456121 *
GILTAY R ET AL: "Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4.", MATRIX BIOLOGY : JOURNAL OF THE INTERNATIONAL SOCIETY FOR MATRIX BIOLOGY. OCT 1999, vol. 18, no. 5, October 1999 (1999-10-01), pages 469 - 480, XP002292355, ISSN: 0945-053X *
See also references of WO0134626A1 *

Also Published As

Publication number Publication date
CA2389305A1 (fr) 2001-05-17
WO2001034626A1 (fr) 2001-05-17
EP1237901A1 (fr) 2002-09-11
JP2003520030A (ja) 2003-07-02
AU1449001A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
EP1218408A4 (fr) 32 proteines humaines secretees
EP1212343A4 (fr) 52 proteines humaines secretees
EP1181390A4 (fr) 27 proteines humaines secretees
EP1224285A4 (fr) 27 proteines humaines secretees
EP1212342A4 (fr) 18 proteines secretees humaines
EP1226231A4 (fr) 19 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1192278A4 (fr) 48 proteines secretees humaines
EP1192176A4 (fr) 49 proteines secretees humaines
EP1165827A4 (fr) 45 proteines humaines secretees
EP1175439A4 (fr) 49 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1189917A4 (fr) 48 proteines humaines secretees
EP1185543A4 (fr) 50 proteines humaines secretees
EP1173477A4 (fr) 49 proteines humaines secretees
EP1224201A4 (fr) 32 proteines humaines secretees
EP1203005A4 (fr) 25 proteines secretees humaines
EP1206573A4 (fr) 26 proteines humaines secretees
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1144614A4 (fr) Proteines humaines secretees (33)
EP1171460A4 (fr) 48 proteines secretees humaines
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1237901A4 (fr) 28 proteines secretees humaines
EP1165828A4 (fr) 50 proteines humaines secretees
EP1185285A4 (fr) 49 proteines secretees humaines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020528

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 38/17 B

Ipc: 7C 12N 15/12 B

Ipc: 7A 61K 31/7088 B

Ipc: 7A 61K 31/713 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 14/47 A

Ipc: 7G 01N 33/68 B

Ipc: 7A 61K 39/395 B

Ipc: 7C 07K 16/18 B

A4 Supplementary search report drawn up and despatched

Effective date: 20041129

17Q First examination report despatched

Effective date: 20050523

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051004